Australia stands at a critical juncture in privacy and artificial intelligence (AI) regulation. The Privacy and Other Legislation Amendment Bill 2024 was passed on 29 November 2024, alongside cybersecurity...
This new whitepaper from LexisNexis covers findings from a series of discussions jointly hosted by LexisNexis and the Governance Institute of Australia with industry leaders, on how organisations can prepare...
As Australian businesses navigate a rapidly changing risk landscape, the importance of digital transformation has never been greater. We’ve collaborated with our technology partner ReadiNow, who...
Ensuring operational resilience has become a critical priority for Australian and New Zealand organizations but navigating the complexities of CPS 230 can be daunting. They will need to establish appropriate...
Ben has observed that he now saves one-third of the time he would typically spend on legal research. Background Clifford Gouldson is a prominent law firm located in Toowoomba, Queensland, with additional...
Does your organisation comply with the State and Territory-based licensing requirements for the supply of therapeutic goods?
Authored in partnership with Kelly Griffiths, Partner at Gadens and Legal Expert for LexisNexis® Regulatory Compliance, this checklist has been designed to help you identify your requirements related to the management and supply of therapeutic goods in Australia.
This checklist covers the classification of therapeutic goods, licensing and sampling requirements, advertising of therapeutic goods and more.
Gain clarity on your therapeutic goods obligations and download the checklist today!
Fill out the form to download the checklist.